We evaluated a combination of transcutaneous electrical nerve stimulation (TENS) and solifenacin succinate versus solifenacin alone in the treatment of overactive bladder (OAB).
Ninety-seven female outpatients with OAB were screened for this double-blind randomized controlled study.